Showing results (21-30 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injectionE M Hersh, J L Murray, W K Hong, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Interleukin-1, stromal cells, granulopoiesis, and the inflammatory responseG C BagbyBiotherapy (Dordrecht, Netherlands)|January 1, 1989
Interleukin-1 is identical to hemopoietin-1: studies on its therapeutic effects on myelopoiesis and lymphopoiesisP J Morrissey, D Y MochizukiBiotherapy (Dordrecht, Netherlands)|January 1, 1989
Stimulation of hematopoiesis and antibacterial resistance by interleukin-1K W McIntyre, J Unowsky, W DeLorenzo, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Interleukin-1 alpha: its possible roles in cancer therapyM Yamada, Y Sohmura, S Nakamura, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Inhibition of interferon-gamma and interleukin-2 production from lymphocytes stimulated with food antigens by an anti-allergic drug, Tranilast, in patients with food-sensitive atopic dermatitisN Kondo, O Fukutomi, M Shinbara, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individualsJ Rivero, M Limonta, A Aguilera, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Antitumor effects of human recombinant macrophage colony-stimulating factor against rat brain tumorsT Matsuoka, T Uozumi, K Kurisu, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 diseaseJ Schüpbach, H Günthard, M S Fung, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Improvement of glucose tolerance with immunomodulators on type 2 diabetic animalsX P Zhu, J Satoh, G Muto, et al.Pageof 33